Press release
Pompe Disease Therapeutic Market to Exhibit Rapid Surge in Consumption in the COVID-19 Crisis
Pompe disease or also referred to as Glycogen storage disease type II is an autosomal recessive metabolic disorder that damages nerve cells and muscles throughout the body. It is typically caused due to the accumulation of glycogen in the lysosome, owing to deficiency of the lysosomal acid alpha-glucosidase enzyme.Rising prevalence of Pompe disease is expected to drive growth of the global Pompe disease therapeutic market during the forecast period. According to the National Organization for Rare Disorders (NORD), around 1 in 40,000 births in the U.S. and the Netherlands are affected with Pompe disease. According to the same source, a recent study showed that the state of Missouri reported a higher prevalence of 1 in 5,463. Pompe disease can occur in various populations and ethnic groups across the globe. According to the Pompe Disease News, around 5,000 to 10,000 people have Pompe diseases worldwide. As a result of this, the demand for new therapeutic treatment options is increasing globally.
Buy Now With Covid-19 Analysis and Updated Information@ https://www.coherentmarketinsights.com/insight/buy-now/1316
Thus, these factors are expected to drive growth of the global Pompe disease therapeutic market during the forecast period. Furthermore, proactive initiatives taken by government authorities to develop and manufacture innovative products for the diagnosis and treatment of rare diseases are expected to propel the global Pompe disease therapeutic market growth over the forecast period.
However, the high cost associated with treatment is expected to hinder the global Pompe disease therapeutic market growth over the forecast period. Continuous research and development activities can present lucrative growth opportunities in the global Pompe disease therapeutic market in the near future. Among regions, North America is expected to witness significant growth in the global Pompe disease therapeutic market during the forecast period. This is owing to the presence of robust healthcare infrastructure across the region. Furthermore, Europe is expected to register a robust growth rate over the forecast period, owing to continuous research and development activities combined with proactive support from government authorities to improve the healthcare sector.
For Further Report Related Query@ https://www.coherentmarketinsights.com/insight/talk-to-analyst/1316
Key companies operating in the global Pompe disease therapeutic market are CENTOGENE AG, Amicus Therapeutics, Inc., AVROBIO, Inc., Sanofi, Valerion Therapeutics, Audentes Therapeutics, and Oxyrane.
For instance, in June 2020, Sanofi announced results of Phase III trial for its investigational enzyme replacement therapy (ERT) avalglucosidase alfa indicated for late-onset Pompe disease (LOPD) with clinically meaningful improvement.
Mr. Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Coherent Market Insights (CMI) is a global market intelligence and consulting organization focused on assisting plethora of clients achieve transformational growth by helping them make critical business decisions.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pompe Disease Therapeutic Market to Exhibit Rapid Surge in Consumption in the COVID-19 Crisis here
News-ID: 2223252 • Views: …
More Releases from Coherent Market Insights

3D Scanning Market Outlook 2025: Business Expansion, Market Trends, and Future P …
The 3D Scanning market is estimated to be valued at USD 3,556.7 Mn in 2025 and is expected to reach USD 12,161.3 Mn by 2032, growing at a compound annual growth rate CAGR of 19.2% from 2025 to 2032.
➤ The latest report "3D Scanning 2025 by Key Players, Regions, Types and Applications, Forecast to 2032" from Coherent Market Insights provides a detailed and comprehensive analysis of the 3D Scanning. The…

Biophotonics Market Set to Reflect Significant Incremental Opportunity from 2025 …
Latest Report, titled "Biophotonics Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
➤ Get a Sample Copy of This Report @ https://www.coherentmarketinsights.com/insight/request-sample/3191
The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis.…

Home Care Service Market Is Booming Rapidly with a 10.4% CAGR Featuring Amedisys …
The home care service industry has witnessed significant transformation driven by shifting demographics and evolving consumer preferences towards personalized healthcare solutions. The rising aging population, coupled with increasing prevalence of chronic diseases, has sparked a surge in demand for in-home medical and non-medical care services. This sector is also benefiting from technological advancements such as telehealth integration and remote patient monitoring, which have enhanced service delivery efficiency and patient outcomes.…

Natural Killer Cell Therapy Market Analysis, Top Companies, Scope, Demand, Oppor …
The exclusive research report on 'Natural Killer Cells Market' now available with Coherent Market Insights, offers a detailed analysis of the factors influencing the global business sphere. This report also provides precise information pertaining to market size, commercialization aspects and revenue estimation of this business. The report further elucidates the status of leading industry players thriving in the competitive spectrum of the Natural Killer Cells Market.
The research report incorporates…
More Releases for Pompe
Pompe Disease Market Trends That Will Shape the Next Decade: Insights from Innov …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Pompe Disease Market Size By 2025?
The market scale for Pompe disease has seen a consistent growth over the past few years. Its size is expected to increase from the current $1.74 billion in 2024 to about $1.8 billion in 2025, exhibiting a compound annual…
Leading Element Driving Change in the Pompe Disease Market in 2025: Rising Preva …
How Are the key drivers contributing to the expansion of the pompe disease market?
The surge in the occurrence of Pompe disease, which is also known as glycogen storage disease type II or acid maltase deficiency, is anticipated to contribute significantly to the expansion of the Pompe disease market. This rare genetic condition is marked by an accumulation of glycogen, or a complex sugar molecule, in muscles and different body tissues.…
Pompe Disease Therapeutics and Treatment Market Report 2024
"The Business Research Company recently released a comprehensive report on the Global Pompe Disease Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Pompe Disease Treatment Drugs, Pipeline Insight Report 2024
DelveInsight's, "Pompe Disease Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Pompe Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Discover the latest drugs and treatment options in the Pompe…
Gaucher & Pompe Diseases Enzyme Replacement Therapy (ERT) Market - Restoring Bal …
Newark, New Castle, USA: The "Gaucher & Pompe Diseases Enzyme Replacement Therapy (ERT) Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Gaucher & Pompe Diseases Enzyme Replacement…
Pompe Disease Therapeutic Market - Increasing prevalence of pompe disease in man …
Pompe Disease Therapeutic Market report is a exploration database spread across colorful runners with multiple tables and numbers in it. The exploration covers a precious source of perceptive information for business strategists. Pompe Disease Therapeutic Industry provides the overview with growth analysis and literal & futuristic cost, profit, demand and force data (as applicable). The exploration judges give an elegant description of the value chain and its distributor analysis.
This comprehensive…